Therapy of Helicobacter pylori:: Current status and issues

被引：102

作者：

Graham, DY

机构：

[1] Vet Affairs Med Ctr 111D, Dept Med, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Med, Houston, TX 77030 USA

[3] Baylor Coll Med, Dept Mol Virol, Houston, TX 77030 USA

来源：

GASTROENTEROLOGY | 2000年 / 118卷 / 02期

关键词：

D O I：

10.1016/S0016-5085(00)70003-5

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：S2 / S8

页数：7

共 51 条

[1]

ALASSI MT, 1994, ALIMENT PHARM THERAP, V8, P259

[2] Ulcer and gastritis [J].

Anand, BS ;

Graham, DY .

ENDOSCOPY, 1999, 31 (02) :215-225

[3] H-pylori (HP) eradication with omeprazole (O), metronidazole (M) and amoxycillin (A):: The impact of drug dosing & resistance on efficacy -: The HOMER story. [J].

Bardhan, KD ;

Bayerdörffer, E ;

Delchier, JP ;

Hellblom, M ;

Mégraud, F ;

Stubberöd, A ;

van Zanten, SJOV ;

Lind, T ;

Burman, CF ;

Gromark, PO .

GASTROENTEROLOGY, 1998, 114 (04) :A65-A65

[4] Efficacy of lansoprazole in eradicating Helicobacter pylori: A meta-analysis [J].

Bazzoli, F ;

Pozzato, P ;

Zagari, M ;

Fossi, S ;

Ricciardiello, L ;

Nicolini, G ;

Berretti, D ;

De Luca, L .

HELICOBACTER, 1998, 3 (03) :195-201

[5]

Breuer T, 1999, AM J GASTROENTEROL, V94, P725, DOI 10.1111/j.1572-0241.1999.00943.x

[6] Clarithromycin, amoxycillin and H-2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea [J].

Breuer, T ;

Kim, JG ;

ElZimaity, HMT ;

Nikajima, S ;

Ota, H ;

Osato, M ;

Graham, DY .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (05) :939-942

[7]

Broutet N, 1998, GUT, V43, pA79

[8] Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy [J].

Catalano, F ;

Branciforte, G ;

Catanzaro, R ;

Bentivegna, C ;

Cipolla, R ;

Nuciforo, G ;

Brogna, A .

HELICOBACTER, 1999, 4 (03) :178-184

[9]

CHIBA N, 1992, AM J GASTROENTEROL, V87, P1716

[10]

CLARK EG, 1964, MED CLIN N AM, V48, P613

← 1 2 3 4 5 6 →